Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 274

1.

Clonidine extended-release tablets for pediatric patients with attention-deficit/hyperactivity disorder.

Jain R, Segal S, Kollins SH, Khayrallah M.

J Am Acad Child Adolesc Psychiatry. 2011 Feb;50(2):171-9. doi: 10.1016/j.jaac.2010.11.005.

PMID:
21241954
[PubMed - indexed for MEDLINE]
3.

Clonidine extended-release tablets as add-on therapy to psychostimulants in children and adolescents with ADHD.

Kollins SH, Jain R, Brams M, Segal S, Findling RL, Wigal SB, Khayrallah M.

Pediatrics. 2011 Jun;127(6):e1406-13. doi: 10.1542/peds.2010-1260. Epub 2011 May 9.

PMID:
21555501
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder.

Biederman J, Melmed RD, Patel A, McBurnett K, Konow J, Lyne A, Scherer N; SPD503 Study Group.

Pediatrics. 2008 Jan;121(1):e73-84. doi: 10.1542/peds.2006-3695.

PMID:
18166547
[PubMed - indexed for MEDLINE]
Free Article
5.

Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study.

Biederman J, Swanson JM, Wigal SB, Kratochvil CJ, Boellner SW, Earl CQ, Jiang J, Greenhill L.

Pediatrics. 2005 Dec;116(6):e777-84.

PMID:
16322134
[PubMed - indexed for MEDLINE]
6.

Effects of guanfacine extended release on oppositional symptoms in children aged 6-12 years with attention-deficit hyperactivity disorder and oppositional symptoms: a randomized, double-blind, placebo-controlled trial.

Connor DF, Findling RL, Kollins SH, Sallee F, López FA, Lyne A, Tremblay G.

CNS Drugs. 2010 Sep;24(9):755-68. doi: 10.2165/11537790-000000000-00000.

PMID:
20806988
[PubMed - indexed for MEDLINE]
8.

Modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, fixed-dose study followed by abrupt discontinuation.

Swanson JM, Greenhill LL, Lopez FA, Sedillo A, Earl CQ, Jiang JG, Biederman J.

J Clin Psychiatry. 2006 Jan;67(1):137-47.

PMID:
16426100
[PubMed - indexed for MEDLINE]
9.

Clonidine extended-release: in attention-deficit hyperactivity disorder.

Croxtall JD.

Paediatr Drugs. 2011 Oct 1;13(5):329-36. doi: 10.2165/11208100-000000000-00000. Review.

PMID:
21888447
[PubMed - indexed for MEDLINE]
10.

[Atomoxetine: a new treatment for Attention Deficit/Hyperactivity Disorder (ADHD) in children and adolescents].

Purper-Ouakil D, Fourneret P, Wohl M, Rénéric JP.

Encephale. 2005 May-Jun;31(3):337-48. Review. French.

PMID:
16142049
[PubMed - indexed for MEDLINE]
11.

Modafinil in children and adolescents with attention-deficit/hyperactivity disorder: a preliminary 8-week, open-label study.

Boellner SW, Earl CQ, Arora S.

Curr Med Res Opin. 2006 Dec;22(12):2457-65.

PMID:
17257460
[PubMed - indexed for MEDLINE]
12.
13.

Randomized, double-blind trial of guanfacine extended release in children with attention-deficit/hyperactivity disorder: morning or evening administration.

Newcorn JH, Stein MA, Childress AC, Youcha S, White C, Enright G, Rubin J.

J Am Acad Child Adolesc Psychiatry. 2013 Sep;52(9):921-30. doi: 10.1016/j.jaac.2013.06.006. Epub 2013 Aug 1.

PMID:
23972694
[PubMed - indexed for MEDLINE]
14.

A randomized, double-blind, placebo-controlled, parallel-group study of SLI381 (Adderall XR) in children with attention-deficit/hyperactivity disorder.

Biederman J, Lopez FA, Boellner SW, Chandler MC.

Pediatrics. 2002 Aug;110(2 Pt 1):258-66.

PMID:
12165576
[PubMed - indexed for MEDLINE]
15.

Safety and effectiveness of coadministration of guanfacine extended release and psychostimulants in children and adolescents with attention-deficit/hyperactivity disorder.

Spencer TJ, Greenbaum M, Ginsberg LD, Murphy WR.

J Child Adolesc Psychopharmacol. 2009 Oct;19(5):501-10. doi: 10.1089/cap.2008.0152.

PMID:
19877974
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Efficacy and safety of dexmethylphenidate extended-release capsules administered once daily to children with attention-deficit/hyperactivity disorder.

Childress AC, Spencer T, Lopez F, Gerstner O, Thulasiraman A, Muniz R, Post A.

J Child Adolesc Psychopharmacol. 2009 Aug;19(4):351-61. doi: 10.1089/cap.2009.0007.

PMID:
19702487
[PubMed - indexed for MEDLINE]
17.

Guanfacine extended-release: in attention deficit hyperactivity disorder.

Muir VJ, Perry CM.

Drugs. 2010 Sep 10;70(13):1693-702. doi: 10.2165/11205940-000000000-00000. Review.

PMID:
20731476
[PubMed - indexed for MEDLINE]
18.

Efficacy of guanfacine extended release in the treatment of combined and inattentive only subtypes of attention-deficit/hyperactivity disorder.

Sallee FR, Kollins SH, Wigal TL.

J Child Adolesc Psychopharmacol. 2012 Jun;22(3):206-14. doi: 10.1089/cap.2010.0135. Epub 2012 May 21.

PMID:
22612526
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Efficacy and safety of dexmethylphenidate extended-release capsules in children with attention-deficit/hyperactivity disorder.

Greenhill LL, Muniz R, Ball RR, Levine A, Pestreich L, Jiang H.

J Am Acad Child Adolesc Psychiatry. 2006 Jul;45(7):817-23.

PMID:
16832318
[PubMed - indexed for MEDLINE]
20.

Treatment of ADHD in children with tics: a randomized controlled trial.

Tourette's Syndrome Study Group.

Neurology. 2002 Feb 26;58(4):527-36.

PMID:
11865128
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk